A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

IsraelRecruitingPHASE1

Conditions

Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

  • Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States

  • Yale Cancer Center, New Haven, Connecticut, United States

  • Florida Cancer Specialist-Lake Mary, Lake Mary, Florida, United States

  • University of Illinois, Chicago, Illinois, United States

  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

  • START - Midwest - EDOS, Grand Rapids, Michigan, United States

  • Montefiore Einstein Cancer Center, The Bronx, New York, United States

  • Mary Crowley Medical Research Center, Dallas, Pennsylvania, United States

  • Abramson Cancer Center;Univ of Pennsylvania, Philadelphia, Pennsylvania, United States

  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • O'Quinn Medical Tower at McNair Campus, Houston, Texas, United States

  • St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia

  • Peter Maccallum Cancer Centre, Parkville, Victoria, Australia

  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  • Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada

  • Institut Bergonie, Bordeaux, France

  • Rambam Health Care Campus, Haifa, Israel

  • Hadassah University Hospital - Ein Kerem, Jerusalem, Israel

  • The Chaim Sheba Medical Center, Ramat Gan, Israel

  • Tel Aviv Sourasky Medical Center PPDS, Tel Aviv, Israel

  • National University Hospital, Singapore, Singapore

  • National Cancer Centre, Singapore, Singapore

  • Seoul National University Bundang Hospital, Seongnam, South Korea

  • Asan Medical Center., Seoul, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON, Barcelona, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • START Madrid_Hospital Universitario HM Sanchinarro_CIOCC, Madrid, Spain

  • Hospital Universitario Virgen de la Victoria, Málaga, Spain

  • Hospital Universitario Virgen del Rocio - PPDS, Seville, Spain

  • Hospital Clinico Universitario de Valencia, Valencia, Spain

  • Western General Hospital;Edinburgh Cancer Center, Edinburgh, Midlothian, United Kingdom

  • NIHR UCLH Clinical Research Facility, London, United Kingdom

  • The Christie, Manchester, United Kingdom

  • Royal Marsden Hospital - Surrey, Sutton, United Kingdom

Study leads
  • Clinical Trials

    Study Director

    Hoffmann-La Roche